Cargando…
Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey
INTRODUCTION: In elderly patients with cervical spinal cord injury, comorbidities such as cardiovascular and cerebrovascular diseases are common, with frequent administration of antiplatelet/anticoagulant (APAC) drugs. Such patients may bleed easily or unexpectedly during surgery despite prior withd...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Spine Surgery and Related Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381072/ https://www.ncbi.nlm.nih.gov/pubmed/36051672 http://dx.doi.org/10.22603/ssrr.2021-0183 |
_version_ | 1784769002734616576 |
---|---|
author | Uehara, Masashi Ikegami, Shota Takizawa, Takashi Oba, Hiroki Yokogawa, Noriaki Sasagawa, Takeshi Ando, Kei Nakashima, Hiroaki Segi, Naoki Funayama, Toru Eto, Fumihiko Yamaji, Akihiro Watanabe, Kota Nori, Satoshi Takeda, Kazuki Furuya, Takeo Orita, Sumihisa Nakajima, Hideaki Yamada, Tomohiro Hasegawa, Tomohiko Terashima, Yoshinori Hirota, Ryosuke Suzuki, Hidenori Imajo, Yasuaki Tonomura, Hitoshi Sakata, Munehiro Hashimoto, Ko Onoda, Yoshito Kawaguchi, Kenichi Haruta, Yohei Suzuki, Nobuyuki Kato, Kenji Uei, Hiroshi Sawada, Hirokatsu Nakanishi, Kazuo Misaki, Kosuke Terai, Hidetomi Tamai, Koji Shirasawa, Eiki Inoue, Gen Kakutani, Kenichiro Kakiuchi, Yuji Kiyasu, Katsuhito Tominaga, Hiroyuki Tokumoto, Hiroto Iizuka, Yoichi Takasawa, Eiji Akeda, Koji Takegami, Norihiko Funao, Haruki Oshima, Yasushi Kaito, Takashi Sakai, Daisuke Yoshii, Toshitaka Ohba, Tetsuro Otsuki, Bungo Seki, Shoji Miyazaki, Masashi Ishihara, Masayuki Okada, Seiji Aoki, Yasuchika Harimaya, Katsumi Murakami, Hideki Ishii, Ken Ohtori, Seiji Imagama, Shiro Kato, Satoshi |
author_facet | Uehara, Masashi Ikegami, Shota Takizawa, Takashi Oba, Hiroki Yokogawa, Noriaki Sasagawa, Takeshi Ando, Kei Nakashima, Hiroaki Segi, Naoki Funayama, Toru Eto, Fumihiko Yamaji, Akihiro Watanabe, Kota Nori, Satoshi Takeda, Kazuki Furuya, Takeo Orita, Sumihisa Nakajima, Hideaki Yamada, Tomohiro Hasegawa, Tomohiko Terashima, Yoshinori Hirota, Ryosuke Suzuki, Hidenori Imajo, Yasuaki Tonomura, Hitoshi Sakata, Munehiro Hashimoto, Ko Onoda, Yoshito Kawaguchi, Kenichi Haruta, Yohei Suzuki, Nobuyuki Kato, Kenji Uei, Hiroshi Sawada, Hirokatsu Nakanishi, Kazuo Misaki, Kosuke Terai, Hidetomi Tamai, Koji Shirasawa, Eiki Inoue, Gen Kakutani, Kenichiro Kakiuchi, Yuji Kiyasu, Katsuhito Tominaga, Hiroyuki Tokumoto, Hiroto Iizuka, Yoichi Takasawa, Eiji Akeda, Koji Takegami, Norihiko Funao, Haruki Oshima, Yasushi Kaito, Takashi Sakai, Daisuke Yoshii, Toshitaka Ohba, Tetsuro Otsuki, Bungo Seki, Shoji Miyazaki, Masashi Ishihara, Masayuki Okada, Seiji Aoki, Yasuchika Harimaya, Katsumi Murakami, Hideki Ishii, Ken Ohtori, Seiji Imagama, Shiro Kato, Satoshi |
author_sort | Uehara, Masashi |
collection | PubMed |
description | INTRODUCTION: In elderly patients with cervical spinal cord injury, comorbidities such as cardiovascular and cerebrovascular diseases are common, with frequent administration of antiplatelet/anticoagulant (APAC) drugs. Such patients may bleed easily or unexpectedly during surgery despite prior withdrawal of APAC medication. Few reports have examined the precise relationship between intraoperative blood loss and history of APAC use regarding surgery for cervical spine injury in the elderly. The present multicenter database survey aimed to answer the question of whether the use of APAC drugs affected the amount of intraoperative blood loss in elderly patients with cervical spinal cord trauma. METHODS: The case histories of 1512 patients with cervical spine injury at 33 institutes were retrospectively reviewed. After excluding cases without spinal surgery or known blood loss volume, 797 patients were enrolled. Blood volume loss was the outcome of interest. We calculated propensity scores using the inverse probability of treatment weighting (IPTW) method. As an alternative sensitivity analysis, linear mixed model analyses were conducted as well. RESULTS: Of the 776 patients (mean age: 75.1±6.4 years) eligible for IPTW calculation, 157 (20.2%) were taking APAC medications before the injury. After weighting, mean estimated blood loss was 204 mL for non-APAC patients and 215 mL for APAC patients. APAC use in elderly patients was not significantly associated with surgical blood loss according to the IPTW method with propensity scoring or linear mixed model analyses. Thus, it appeared possible to perform surgery expecting comparable blood loss in APAC and non-APAC cases. CONCLUSIONS: This multicenter study revealed no significant increase in surgical blood loss in elderly patients with cervical trauma taking APAC drugs. Surgeons may be able to prioritize patient background, complications, and preexisting conditions over APAC use before injury when examining the surgical indications for cervical spine trauma in the elderly. |
format | Online Article Text |
id | pubmed-9381072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Japanese Society for Spine Surgery and Related Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-93810722022-08-31 Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey Uehara, Masashi Ikegami, Shota Takizawa, Takashi Oba, Hiroki Yokogawa, Noriaki Sasagawa, Takeshi Ando, Kei Nakashima, Hiroaki Segi, Naoki Funayama, Toru Eto, Fumihiko Yamaji, Akihiro Watanabe, Kota Nori, Satoshi Takeda, Kazuki Furuya, Takeo Orita, Sumihisa Nakajima, Hideaki Yamada, Tomohiro Hasegawa, Tomohiko Terashima, Yoshinori Hirota, Ryosuke Suzuki, Hidenori Imajo, Yasuaki Tonomura, Hitoshi Sakata, Munehiro Hashimoto, Ko Onoda, Yoshito Kawaguchi, Kenichi Haruta, Yohei Suzuki, Nobuyuki Kato, Kenji Uei, Hiroshi Sawada, Hirokatsu Nakanishi, Kazuo Misaki, Kosuke Terai, Hidetomi Tamai, Koji Shirasawa, Eiki Inoue, Gen Kakutani, Kenichiro Kakiuchi, Yuji Kiyasu, Katsuhito Tominaga, Hiroyuki Tokumoto, Hiroto Iizuka, Yoichi Takasawa, Eiji Akeda, Koji Takegami, Norihiko Funao, Haruki Oshima, Yasushi Kaito, Takashi Sakai, Daisuke Yoshii, Toshitaka Ohba, Tetsuro Otsuki, Bungo Seki, Shoji Miyazaki, Masashi Ishihara, Masayuki Okada, Seiji Aoki, Yasuchika Harimaya, Katsumi Murakami, Hideki Ishii, Ken Ohtori, Seiji Imagama, Shiro Kato, Satoshi Spine Surg Relat Res Original Article INTRODUCTION: In elderly patients with cervical spinal cord injury, comorbidities such as cardiovascular and cerebrovascular diseases are common, with frequent administration of antiplatelet/anticoagulant (APAC) drugs. Such patients may bleed easily or unexpectedly during surgery despite prior withdrawal of APAC medication. Few reports have examined the precise relationship between intraoperative blood loss and history of APAC use regarding surgery for cervical spine injury in the elderly. The present multicenter database survey aimed to answer the question of whether the use of APAC drugs affected the amount of intraoperative blood loss in elderly patients with cervical spinal cord trauma. METHODS: The case histories of 1512 patients with cervical spine injury at 33 institutes were retrospectively reviewed. After excluding cases without spinal surgery or known blood loss volume, 797 patients were enrolled. Blood volume loss was the outcome of interest. We calculated propensity scores using the inverse probability of treatment weighting (IPTW) method. As an alternative sensitivity analysis, linear mixed model analyses were conducted as well. RESULTS: Of the 776 patients (mean age: 75.1±6.4 years) eligible for IPTW calculation, 157 (20.2%) were taking APAC medications before the injury. After weighting, mean estimated blood loss was 204 mL for non-APAC patients and 215 mL for APAC patients. APAC use in elderly patients was not significantly associated with surgical blood loss according to the IPTW method with propensity scoring or linear mixed model analyses. Thus, it appeared possible to perform surgery expecting comparable blood loss in APAC and non-APAC cases. CONCLUSIONS: This multicenter study revealed no significant increase in surgical blood loss in elderly patients with cervical trauma taking APAC drugs. Surgeons may be able to prioritize patient background, complications, and preexisting conditions over APAC use before injury when examining the surgical indications for cervical spine trauma in the elderly. The Japanese Society for Spine Surgery and Related Research 2021-12-27 /pmc/articles/PMC9381072/ /pubmed/36051672 http://dx.doi.org/10.22603/ssrr.2021-0183 Text en Copyright © 2022 by The Japanese Society for Spine Surgery and Related Research https://creativecommons.org/licenses/by-nc-nd/4.0/Spine Surgery and Related Research is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Uehara, Masashi Ikegami, Shota Takizawa, Takashi Oba, Hiroki Yokogawa, Noriaki Sasagawa, Takeshi Ando, Kei Nakashima, Hiroaki Segi, Naoki Funayama, Toru Eto, Fumihiko Yamaji, Akihiro Watanabe, Kota Nori, Satoshi Takeda, Kazuki Furuya, Takeo Orita, Sumihisa Nakajima, Hideaki Yamada, Tomohiro Hasegawa, Tomohiko Terashima, Yoshinori Hirota, Ryosuke Suzuki, Hidenori Imajo, Yasuaki Tonomura, Hitoshi Sakata, Munehiro Hashimoto, Ko Onoda, Yoshito Kawaguchi, Kenichi Haruta, Yohei Suzuki, Nobuyuki Kato, Kenji Uei, Hiroshi Sawada, Hirokatsu Nakanishi, Kazuo Misaki, Kosuke Terai, Hidetomi Tamai, Koji Shirasawa, Eiki Inoue, Gen Kakutani, Kenichiro Kakiuchi, Yuji Kiyasu, Katsuhito Tominaga, Hiroyuki Tokumoto, Hiroto Iizuka, Yoichi Takasawa, Eiji Akeda, Koji Takegami, Norihiko Funao, Haruki Oshima, Yasushi Kaito, Takashi Sakai, Daisuke Yoshii, Toshitaka Ohba, Tetsuro Otsuki, Bungo Seki, Shoji Miyazaki, Masashi Ishihara, Masayuki Okada, Seiji Aoki, Yasuchika Harimaya, Katsumi Murakami, Hideki Ishii, Ken Ohtori, Seiji Imagama, Shiro Kato, Satoshi Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey |
title | Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey |
title_full | Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey |
title_fullStr | Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey |
title_full_unstemmed | Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey |
title_short | Is Blood Loss Greater in Elderly Patients under Antiplatelet or Anticoagulant Medication for Cervical Spine Injury Surgery? A Japanese Multicenter Survey |
title_sort | is blood loss greater in elderly patients under antiplatelet or anticoagulant medication for cervical spine injury surgery? a japanese multicenter survey |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381072/ https://www.ncbi.nlm.nih.gov/pubmed/36051672 http://dx.doi.org/10.22603/ssrr.2021-0183 |
work_keys_str_mv | AT ueharamasashi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT ikegamishota isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT takizawatakashi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT obahiroki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT yokogawanoriaki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT sasagawatakeshi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT andokei isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT nakashimahiroaki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT seginaoki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT funayamatoru isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT etofumihiko isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT yamajiakihiro isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT watanabekota isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT norisatoshi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT takedakazuki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT furuyatakeo isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT oritasumihisa isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT nakajimahideaki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT yamadatomohiro isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT hasegawatomohiko isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT terashimayoshinori isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT hirotaryosuke isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT suzukihidenori isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT imajoyasuaki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT tonomurahitoshi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT sakatamunehiro isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT hashimotoko isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT onodayoshito isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT kawaguchikenichi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT harutayohei isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT suzukinobuyuki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT katokenji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT ueihiroshi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT sawadahirokatsu isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT nakanishikazuo isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT misakikosuke isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT teraihidetomi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT tamaikoji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT shirasawaeiki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT inouegen isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT kakutanikenichiro isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT kakiuchiyuji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT kiyasukatsuhito isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT tominagahiroyuki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT tokumotohiroto isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT iizukayoichi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT takasawaeiji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT akedakoji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT takegaminorihiko isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT funaoharuki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT oshimayasushi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT kaitotakashi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT sakaidaisuke isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT yoshiitoshitaka isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT ohbatetsuro isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT otsukibungo isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT sekishoji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT miyazakimasashi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT ishiharamasayuki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT okadaseiji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT aokiyasuchika isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT harimayakatsumi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT murakamihideki isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT ishiiken isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT ohtoriseiji isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT imagamashiro isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey AT katosatoshi isbloodlossgreaterinelderlypatientsunderantiplateletoranticoagulantmedicationforcervicalspineinjurysurgeryajapanesemulticentersurvey |